Paper-based Electrochemical Point-of-care Device in Diagnostic of Orthopedic Infections

Last updated: October 29, 2024
Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Overall Status: Active - Recruiting

Phase

N/A

Condition

Ankylosing Spondylitis

Treatment

Device

Clinical Study ID

NCT06666023
PNRR-POC-2023-12378291
  • Ages > 18
  • All Genders

Study Summary

Periprosthetic Joint infections (PJI) and spondylodiscitis are considered some of the most costly infectious diseases because require at least one surgery, prolonged hospitalisation, rehabilitation care, prolonged antibiotherapy, and extended absence from work in working-age patients. Ortho-PoC will face this issue with a smart and highly innovative diagnostic tool, starting from the point-of-care device for infection diagnosis in the orthopedic field developed and published by the coordinator Fondazione Policlinico Universitario Agostino Gemelli IRCCS and one partner Università degli Studi di Roma Tor Vergata. Ortho-PoC will further go beyond the state of the art by delivering a point-of-care device based on multiparametric analysis, in easily collected synovial fluids or pus. Several samples will be analysed using Ortho-PoC at three different Hospitals (Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Ospedali Riuniti di Foggia, Azienza Ospedaliera Universitaria Policlinico Vanvitelli Napoli) and the data will be treated with artificial intelligence (AI) to deliver an AI-assisted robust, effective, and smart diagnostic device for PJI.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • patients that received a joint implant or spine surgery, clear signs of infection (according to international guidelines)

  • patients off antibiotic therapy at least for two weeks

  • Sample biopsy of minimum 1 ml.

Exclusion

Exclusion Criteria:

  • pregnant women,

  • patient affected by cancer

  • patient under antibiotic therapy

Study Design

Total Participants: 400
Treatment Group(s): 1
Primary Treatment: Device
Phase:
Study Start date:
September 01, 2024
Estimated Completion Date:
September 01, 2026

Connect with a study center

  • Fondazione Policlinico Gemelli IRCCS

    Roma, Lazio 00168
    Italy

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.